Glaukos Corporation
GKOSNYSEHealthcare● Active
$125.00
+$3.31(+2.72%)
Market Cap$7.3B
P/E Ratio—
52W High$148.11
52W Low$73.16
Glaukos Corporation (GKOS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GKOS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.51B | $0.38B | $0.31B | $0.28B | $0.29B |
| Cost of Revenue | $0.11B | $0.09B | $0.08B | $0.07B | $0.07B |
| Gross Profit | $0.39B | $0.29B | $0.24B | $0.21B | $0.23B |
| Gross Margin %(computed) | 77.49% | 75.48% | 75.99% | 75.61% | 77.34% |
| Operating Expenses | |||||
| R&D Expenses | $0.15B | $0.14B | $0.14B | $0.12B | $0.10B |
| G&A Expenses | $0.00B | $0.26B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.48B | $0.41B | $0.37B | $0.30B | $0.26B |
| Operating Income | ($0.09B) | ($0.12B) | ($0.13B) | ($0.08B) | ($0.03B) |
| Operating Margin %(computed) | -17.09% | -31.91% | -40.89% | -29.10% | -11.18% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | ($0.19B) | ($0.15B) | ($0.13B) | ($0.10B) | ($0.05B) |
| Income Tax Expense | ($0.01B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.19B) | ($0.15B) | ($0.13B) | ($0.10B) | ($0.05B) |
| Net Margin %(computed) | -36.99% | -38.17% | -42.79% | -35.07% | -16.87% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.28 | $-2.77 | $-2.78 | $-2.09 | $-1.07 |
| Wtd Avg Shares | 0.06B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.04B) | ($0.10B) | ($0.08B) | ($0.05B) | ($0.00B) |
| EBITDA Margin %(computed) | -8.75% | -24.94% | -26.09% | -17.24% | -0.50% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Glaukos Corporation data
About Glaukos Corporation (GKOS) Income Statement
Glaukos Corporation (GKOS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GKOS reported revenue of $0.51B, gross profit of $0.39B (gross margin 77.49%), and net income of ($0.19B) — a net profit margin of -36.99%.
Frequently asked questions
GKOS · 4 questionsGlaukos Corporation (GKOS) reported revenue of $0.51B for 2025, up 32.3% year-over-year.
GKOS revenueGKOS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08